Tekstvak: Machine Preservation Trial  

Tekstvak: Introduction

Tekstvak: The Machine Preservation Trial is the first large  international, multicenter randomized controlled trial to investigate the relevance of Machine Preservation of human kidney grafts, as compared to Cold Storage, today’s Golden Standard in kidney preservation. Starting from November 1 2005, from each kidney donor >15 years of age, one kidney will be preserved by hypothermic machine perfusion and the contralateral kidney will be cold stored. Inclusion of cases will continue for one year. Every recipient will be followed up for one year. This website contains the most important information concerning the Machine Preservation Trial. For any questions, feel free to contact the trial Secretary.   Donors included (until 31-10-06):  338 Additional inclusions after 31-10-06: NHB donors (NL and B):  40 (total=82) 65+ donors (Germany):  32 (total=84) Click here to view main inclusions per region      

.